For us long term followers (2003), we know there has been a lot...

For us long term followers (2003), we know there has been a lot of money spent on ATL1102 (some spent on ATL1103 & tiny spent on ATL1102) , it is worth something. AND this RNA technology is now much more proven then in 2003, IONS is now a USD 5bn mkt cap (got to $10 bn) was $1 bn when they sold ATL1101/3 to ANP (now PER) . Never really understood the pivot to DMD when they were well on track with MS , so maybe it was the wrong pivot and the baby has been thrown out with bathwater? Kenley, Garner and PVL all potentially think so

What remains amazing to me is 850 million shares dumped at 0.0075 average on the poor trial results.. I've never seen capitulation like that in a company that has no debt and cash in the bank. I mean almost everyone gave up entirely -60% below cash backing. Will take months for all that stock to find a home unless PER has a few 00 million share trading days , but eventually it will